Get the Weekly Intelligence Brief — top committee picks every Sunday.

CDW vs NICE

CDW Corporation vs NICE Ltd. — AI-powered side-by-side comparison
CDW
CDW Corporation
54
Watch
VS
NICE
NICE Ltd.
65
Buy
MetricCDWNICE
AI Score 54 65
Price $139.59 $100.12
P/E Ratio 17.02× 14.36×
ROE 40.9% 15.8%
Revenue Growth YoY
Gross Margin 21.4% 65.1%
Debt / Equity 2.44× 0.02×
Dividend Yield 1.8% 0.0%
RSI (14) 58.2 50.7
Beta 0.94 0.035
Expected Upside +1.0% +17.7%

AI Committee View

Current Innellis committee reasoning for CDW versus NICE.
NICE leads by 11 points.

NICE scores 65/100 (Buy) versus CDW at 54/100 (Watch).

CDW Committee View
50% agreement
6 analysts

The committee is genuinely divided. Macro Analyst sees a compelling case. Risk Analyst remains cautious — high leverage (debt-to-equity 2.16) amplifies downside in a stress scenario. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • ROE of 42.6% shows genuine earnings power backing the valuation — Value
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
  • Price-to-book of 6.8x prices in significant intangible value — Value
  • Debt-to-equity of 2.16 adds balance-sheet risk to the value case — Value
  • MACD histogram negative -- bearish momentum — Technical
NICE Committee View
83% agreement
6 analysts

The primary driver is low leverage (debt-to-equity 0.00) -- balance sheet can absorb a shock. The main limiting factor is macd histogram negative -- bearish momentum. The committee is constructive but not yet at full conviction.

Bull Case
  • P/E of 10.8 is inexpensive for the broad market — Value
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • Low leverage (debt-to-equity 0.00) -- balance sheet can absorb a shock — Risk
Bear Case
  • MACD histogram negative -- bearish momentum — Technical
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
CDW Full Analysis NICE Full Analysis